⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18911648 | 0.75 | — | — | |
| SCHEMBL27633634 | 0.75 | — | — | |
| SCHEMBL6006679 | 0.74 | — | — | |
| SCHEMBL27903147 | 0.74 | — | — | |
| SCHEMBL6007468 | 0.74 | — | — | |
| SCHEMBL5300713 | 0.72 | FOLH1 (0.30) | — | |
| SCHEMBL9008793 | 0.72 | CYP19A1 (0.30) | — | |
| SCHEMBL6599022 | 0.69 | CYP19A1 (0.39) | — | |
| SCHEMBL28477420 | 0.69 | CYP19A1 (0.32) | — | |
| SCHEMBL29175107 | 0.68 | PRMT3 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110191701-A | Composition is used in protein intensity reinforcing | 株式会社LG生活健康 | 2019-08-30 | — | — | CN | claimed |
| EP-4736854-A2 | HETEROCYCLIC COMPOUNDS AS MODULATORS OF BCL6 AS LIGAND DIRECTED DEGRADERS | Bristol-Myers Squibb Company (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20250376709-A1 | PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL | UNIV UTAH RES FOUND (US) | 2025-12-11 | — | — | US | disclosed |
| WO-2025085727-A1 | PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL | BANDARIAN VAHE (US) | 2025-04-24 | — | — | WO | disclosed |
| CN-114671864-B | Heteroaryl substituted pyridines and methods of use | 艾伯维公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-4508235-A2 | PAPB AS A BIMOIETY-DEPENDENT THIOETHER INSTALLATION TOOL | University of Utah Research Foundation (US) | 2025-02-19 | — | — | EP | disclosed |
| CN-119119234-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119119233-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| CN-119119235-A | Acylated glucagon analogues | 西兰制药公司 | 2024-12-13 | — | — | CN | disclosed |
| WO-2024212999-A1 | CBL-B INHIBITOR | 微境生物医药科技(上海)有限公司 | 2024-10-17 | — | — | WO | disclosed |
| CN-101087601-A | Compounds for inhibiting copper-containing amine oxidases and uses thereof | GENMEDICA THERAPEUTICS SL (ES) | 2007-12-12 | — | — | CN | disclosed |
| CN-101039920-A | 2,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists | AVENTIS PHARMA INC (US) | 2007-09-19 | — | — | CN | disclosed |
| CN-101010060-A | Keratin dyeing compounds, keratin dyeing compositions containing them and their use | PROCTER & GAMBLE (US) | 2007-08-01 | — | — | CN | disclosed |
| CN-1816527-A | Nitrogen-containing heteroaryl compounds and their use in increasing endogenous erythropoietin | FIBROGEN INC (US) | 2006-08-09 | — | — | CN | disclosed |
| US-20050239786-A1 | Triazole derivatives as tachykinin receptor antagonists | ELI LILLY COMPANY (US) | 2005-10-27 | — | — | US | disclosed |
| US-6774243-B2 | BIOSYNTHESIS OF VIRICIDE | AGOURON PHARMACEUTICALS, INC. | 2004-08-10 | — | — | US | disclosed |
| CN-1157391-C | Processes and intermediates for the preparation of isoxazole carboxamides and analogues thereof | ������ҩ������˾ | 2004-07-14 | — | — | CN | disclosed |
| CN-1452632-A | Extended native chemical ligation | GRYPHON SCIENCES INC (US) | 2003-10-29 | — | — | CN | disclosed |
| CN-1413213-A | Azaindoles | AVENTIS PHARMA LTD (GB) | 2003-04-23 | — | — | CN | disclosed |
| WO-2000043547-A1 | DNA MOBILITY MODIFIER | NORTHWESTERN UNIVERSITY (US) | 2000-07-27 | — | — | WO | disclosed |